Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Radient Technologies Inc RDDTF


Primary Symbol: V.RTI.H

Radient Technologies Inc. is a science-based company. The Company is a commercial manufacturer of cannabinoid-based formulations, ingredients, and products. The principal activities of the Company and its subsidiaries are engaged in research, development, and commercialization of an efficient and environmentally responsible technology for the extraction, isolation, and purification of soluble products from a range of materials using microwave technology and a customized hydrocarbon extraction platform. The Company is focused on the formulation, manufacturing and launching of value-added cannabis products. It utilizes a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant. It develops specialty products and ingredients that contain a range of cannabinoid and terpene profiles.


TSXV:RTI.H - Post by User

Comment by JesseBon Oct 18, 2019 1:50am
246 Views
Post# 30242847

RE:Questions are being raised between ACB & RTI’s dealings

RE:Questions are being raised between ACB & RTI’s dealings Radient's q1 2020 report says they purchased 19.5 million from Aurora July 8 2019. It goes 9n to state they have secured buyers for this bio mass. Quite reasonable to think LPs that are lacking production capacity to build derivative products will buy from Radient. Aphria was clearly lacking capacity to meet initial obligations for supply agreement. How nice this report is issued the day ACB gets some traction and OCT 17 - cannabis 2.0....


<< Previous
Bullboard Posts
Next >>